Trial NCT04364009

View at ClinicalTrials.gov 
Org. Study IDs: ANACONDA-COVID-19
Secondary IDs: 2020-001734-36 DR200111

Last trial update was posted on 2021-01-15

MeSH Interventions

Interleukin 1 Receptor Antagonist Protein

MeSH Conditions

COVID-19 Signs and Symptoms, Respiratory

Other Conditions

ANAKINRA Treatment COVID-19 Infection Optimized Standard of Care (oSOC)

Stopping Reasons

Efficiency and safety reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID